HEXAMETHYLMELAMINE - A CRITICAL-REVIEW OF AN ACTIVE-DRUG

被引：42

作者：

FOSTER, BJ

HARDING, BJ

LEYLANDJONES, B

HOTH, D

机构：

来源：

CANCER TREATMENT REVIEWS | 1986年 / 13卷 / 04期

关键词：

D O I：

10.1016/0305-7372(86)90006-X

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：197 / 217

页数：21

共 102 条

[1]

ALBERTS D, 1985, CANCER TREAT REV SA, P83

[2]

AMES MM, 1982, CANCER TREAT REP, V66, P1579

[3] IRREVERSIBLE ENZYME-INHIBITORS .196. ACTIVE-SITE-DIRECTED IRREVERSIBLE INHIBITORS OF DIHYDROFOLATE REDUCTASE DERIVED FROM 1-(4-BENZYLOXY-3-CHLOROPHENYL)-4,6-DIAMINO-1,2-DIHYDRO-2,2-DIMETHYL-S-TRIAZINE AND BEARING A TERMINAL PHENYL SULFONATE GROUP [J].

BAKER, BR ;

ASHTON, WT .

JOURNAL OF MEDICINAL CHEMISTRY, 1972, 15 (09) :945-&

[4]

BARNES TC, 1966, ARCH INT PHARMACODYN, V1, P83

[5] ASSAYS OF DRUG SENSITIVITY FOR CELLS FROM HUMAN-TUMORS - INVITRO AND INVIVO TESTS ON A XENOGRAFTED TUMOR [J].

BATEMAN, AE ;

PECKHAM, MJ ;

STEEL, GG .

BRITISH JOURNAL OF CANCER, 1979, 40 (01) :81-88

[6]

BENNETT JM, 1977, CANCER TREAT REP, V61, P1079

[7]

BERGEVIN PR, 1973, CANCER CHEMOTH REP 1, V57, P51

[8]

BOLIS G, 1979, CANCER TREAT REP, V63, P1375

[9]

BONOMI PD, 1979, CANCER TREAT REP, V63, P137

[10] HEXAMETHYLMELAMINE TREATMENT OF SARCOMAS AND LYMPHOMAS [J].

BORDEN, EC ;

LARSON, P ;

ANSFIELD, FJ ;

BRYAN, GT ;

JOHNSON, RO ;

RAMIREZ, G ;

WILSON, WL .

MEDICAL AND PEDIATRIC ONCOLOGY, 1977, 3 (04) :401-406

← 1 2 3 4 5 6 7 8 9 10 →